lactic acid and mobic
lactic acid has been researched along with mobic in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Barcia, E; Fernández-Carballido, A; Montejo, C; Negro, S | 1 |
| Dogan, AL; Esendagli, G; Gönül, N; Guc, D; Hasçiçek, C; Şengel-Türk, CT | 1 |
| Ahmed, TA; Hussain, MD; Ibrahim, HM; Kaseem, AA; Nutan, MT; Rahman, Z; Samy, AM | 1 |
| Aguilera-Aguilera, R; Buzon-Cuevas, A; Gonzalez-De Cara, C; Mendoza Garcia, FJ; Perez-Ecija, A | 1 |
Other Studies
5 other study(ies) available for lactic acid and mobic
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Lactic Acid; Male; Meloxicam; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Thiazines; Thiazoles; Time Factors | 2010 |
Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Biological Transport; Cell Survival; Chemistry, Pharmaceutical; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Drug Carriers; Drug Stability; HT29 Cells; Humans; Kinetics; Lactic Acid; Meloxicam; Molecular Weight; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Solubility; Surface Properties; Thiazines; Thiazoles | 2012 |
Development of meloxicam in situ implant formulation by quality by design principle.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Gels; Inhibitory Concentration 50; Lactic Acid; Male; Meloxicam; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Thiazines; Thiazoles; Viscosity; X-Ray Diffraction | 2014 |
Meloxicam ameliorates the systemic inflammatory response syndrome associated with experimentally induced endotoxemia in adult donkeys.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Endotoxemia; Equidae; Female; Interleukin-1beta; Lactic Acid; Lipopolysaccharides; Meloxicam; Monocytes; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2020 |